MyAverix Finance
US · Healthcare
Vincerx Pharma, Inc. Common Stock (VINC)
Biotechnology
Vincerx Pharma, Inc. Common Stock (VINC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VINC
Vincerx Pharma, Inc. Common Stock (VINC) — FAQ
What is VINC's P/E ratio?
The price-to-earnings (P/E) ratio for Vincerx Pharma, Inc. Common Stock (VINC) is 18.00 (data as of 2026-03-25).
Does Vincerx Pharma, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Vincerx Pharma, Inc. Common Stock (VINC). Check the MyAverix Finance app for the latest dividend data.
What sector is Vincerx Pharma, Inc. Common Stock in?
Vincerx Pharma, Inc. Common Stock (VINC) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VINC listed on?
VINC is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.